Madlock-Brown, Charisse
Wilkens, Ken
Weiskopf, Nicole
Cesare, Nina
Bhattacharyya, Sharmodeep
Riches, Naomi O.
Espinoza, Juan
Dorr, David
Goetz, Kerry
Phuong, Jimmy
Sule, Anupam
Kharrazi, Hadi
Liu, Feifan
Lemon, Cindy
Adams, William G.
Funding for this research was provided by:
U.S. National Library of Medicine (1R21LM013645-01)
National Institute of Diabetes and Digestive and Kidney Diseases (5T32DK110966-04)
National Center for Advancing Translational Sciences (U24TR002306, U24TR002306, U24TR002306, U24TR002306, 1UL1TR001430-01)
Article History
Received: 12 November 2021
Accepted: 28 March 2022
First Online: 14 April 2022
Change Date: 24 June 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12889-022-13562-6
Declarations
:
: This research was performed in accordance with all relevant guidelines and regulations.
: None applicable.
: Some of our co-authors do have potential competing interests. Nicole G. Weiskopf has provided consulting for Merck & Co., Inc. Merck had no role in this work. Juan Espinoza is a paid consultant for AI Health. AI Health had no role in this work. Charisse Madlock-Brown, Ken Wilkens, Nina Cesare, Sharmodeep Bhattacharyya, Naomi Riches, David Dorr, Kerry Goetz, Jimmy Phuong, Anupam Sule, Hadi Kharrazi, Feifan Liu, Cindy Lemon, and William G. Adams declare that they have no competing interests.